Impax Laboratories Inc. (IPXL)
NASDAQ: IPXL
· Real-Time Price · USD
18.30
0.00 (0.00%)
At close: Jun 29, 2019, 12:07 AM
Impax Laboratories Revenue Breakdown
| Period Ending | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Generics Revenue | 82.16M | 584.37M | 622.25M | 663.17M | 128.92M | 136.01M | 168.59M | 119.95M | 167.18M | 226.85M | 180.67M | 174.68M | 128.74M |
| Impax Generics Revenue Growth | -85.94% | -6.09% | -6.17% | +414.39% | -5.21% | -19.32% | +40.55% | -28.25% | -26.30% | +25.56% | +3.43% | +35.68% | n/a |
| Impax Specialty Pharma Revenue | 97.22M | 111.92M | 107.41M | 84.24M | 50.26M | 59.22M | 52.59M | 50.9M | 55.43M | 55.25M | 40.43M | 39.5M | 14.36M |
| Impax Specialty Pharma Revenue Growth | -13.14% | +4.20% | +27.50% | +67.62% | -15.14% | +12.62% | +3.33% | -8.18% | +0.33% | +36.64% | +2.35% | +175.19% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 142.86M | 64.02M | 53.59M | 51.62M | 47.05M | 57.59M | 55.04M | 44.91M | 44.3M | 56.51M | 46.31M | 48.31M | 50.16M |
| Selling, General, and Administrative Revenue Growth | +123.16% | +19.47% | +3.82% | +9.69% | -18.29% | +4.63% | +22.56% | +1.38% | -21.61% | +22.04% | -4.14% | -3.69% | n/a |
| Research and Development Revenue | 12.3M | 202.42M | 15.82M | 26.85M | 28.57M | 43.78M | 48.88M | 21.75M | 19.02M | 26.39M | 18.63M | 17M | 14.96M |
| Research and Development Revenue Growth | -93.93% | +1179.44% | -41.07% | -6.02% | -34.74% | -10.45% | +124.80% | +14.32% | -27.93% | +41.67% | +9.63% | +13.59% | n/a |
| Sales and Marketing Revenue | 85.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |